Cancer of the Ureter Completed Phase 2 Trials for Carotuximab (DB06322)

Also known as: Ureteric cancer / Ureteric cancer NOS / Cancer of Ureter / Malignant tumor of ureter (disorder) / Ureteral cancer / Ureter cancer / Malignant neoplasm of ureter

IndicationStatusPhase
DBCOND0051315 (Cancer of the Ureter)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01328574TRC105 in Adults With Advanced/Metastatic Urothelial CarcinomaTreatment